Can modulating redox status help to enhance antituberculosis drug efficacy? - 15/01/19
Doi : 10.1016/j.tube.2018.10.002
Wing Wai Yew
Stanley Ho Centre for Emerging Infectious Diseases, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China
Kwok Chiu Chang
Tuberculosis and Chest Service, Centre for Health Protection, Department of Health, Hong Kong, China
Denise P. Chan ⁎ 
Stanley Ho Centre for Emerging Infectious Diseases, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China
∗Corresponding author. Stanley Ho Centre for Emerging Infectious Diseases, 207 Postgraduate Education Centre, Prince of Wales Hospital Shatin, Hong Kong, China.Stanley Ho Centre for Emerging Infectious DiseasesPrince of Wales Hospital Shatin207 Postgraduate Education CentreHong Kong, China
Ying Zhang
Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
Le texte complet de cet article est disponible en PDF.
Plan
© 2018
Elsevier Ltd. Tous droits réservés.
Vol 113
P. 177-178 - décembre 2018 Retour au numéro
Article précédent
- Reactive nitrogen and oxygen species: Friend or foe in the tuberculosis fight
- Jordana Galizia, Marcelo A. Martí
- Systematic neglect of men as a key population in tuberculosis
- Katherine C. Horton, Richard G. White, Rein M.G.J. Houben
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?